Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma

Modern Pathology

Volumn 18, Issue 1, 2005, Pages 90-96

  Tzankov, Alexandar ^a   Zimpfer, Annette ^a,b   Went, Philip ^b   Maurer, Robert ^c   Pileri, Stefano A ^d   Geley, Stephan ^a   Dirnhofer, Stephan ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cyclin A; Cyclin dependent kinase inhibitors; Hodgkin's lymphoma; p21CIP1; p27KIP1; PCNA; Tissue microarray

Indexed keywords

CELL MARKER; CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REED STERNBERG CELL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHILD; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; REED-STERNBERG CELLS;

EID: 12344325084     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800276     Document Type: Article

References (34)

1. Leoncini L, Megha T, Lazzi S, et al. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1. Int J Cancer 1998;77:408-414.
2. Spina D, Leoncini L, Close P, et al. Growth vs DNA strand breaks in Hodgkin's disease: impaired proliferative ability of Hodgkin and Reed-Sternberg cells. Int J Cancer 1996;66:179-183.
3. Kanavaros P, Stefanaki K, Vlachonikolis J, et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki-67 proteins in Hodgkin's lymphomas. Histol Histopathol 2000;15:445-453.
4. Schmid C, Sweeney E, Isaacson PG. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease. J Pathol 1992;168:1-6.
5. Zimmet J, Ravid K. Polyploidy: occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol 2000;28:3-16.
6. Tzankov A, Zimpfer A, Lugli A, et al. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. J Pathol 2003;199:201-207.
7. Blain SW, Montalvo E, Massague J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem 1997;272:25863-25872.
8. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000;1471:43-56.
9. Dulic V, Stein GH, Far DF, et al. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 1998;18:546-557.
10. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
11. D'Angiolella V, Costanzo V, Gottesman ME, et al. Role for cyclin-dependent kinase 2 in mitosis exit. Curr Biol 2001;11:1221-1226.
12. Sheaff RJ, Groudine M, Gordon M, et al. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997;11:1464-1478.
13. Gillett CE, Barnes DM. Demystified ... cell cycle. J Clin Pathol: Mol Pathol 1998;51:310-316.
14. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60:3689-3695.
15. den Elzen N, Pines J. Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J Cell Biol 2001;153:121-136.
16. Geley S, Kramer E, Gieffers C, et al. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol 2001;153:137-148.
17. Tzankov A, Zimpfer A, Pehrs A, et al. Expression of B-cell markers in classical Hodgkin's lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003;16:1141-1147.
18. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin's lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid System. IARC Press: Lyon, 2001, pp 244-253.
19. Chan WC. The Reed-Sternberg cell in classical Hodgkin's disease. Hematol Oncol 2001;19:1-17.
20. Lorenzen J, Thiele J, Fischer R. The mummified Hodgkin cell: cell death in Hodgkin's disease. J Pathol 1997;182:288-298.
21. Elenitoba-Johnson KS, Medeiros LJ, Khorsand J, et al. p53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 1996;106:728-738.
22. Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle check-points: analysis using tissue microarrays. Blood 2003;101:681-689.
23. Kolar Z, Flavell JR, Ehrmann J, et al. Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1. J Pathol 2000;190:604-612.
24. Naresh KN, O'Conor GT, Soman CS, et al. A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse. Hum Pathol 1997;28:549-555.
25. Ohshima K, Haraoka S, Fujiki T, et al. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression. Pathol Int 1999;49:506-512.
26. Sanchez-Aguilera A, Delgado J, Camacho FI, et al. Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin's lymphomas. Blood 2004;103:2351-2357.
27. Tzankov A, Krugmann J, Fend F, et al. The prognostic significance of CD20 expression in classical Hodgkin's lymphoma - a clinico-pathological study of 119 cases. Clin Cancer Res 2003;9:1381-1386.
28. Kuppers R, Brauninger A, Muschen M, et al. Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions. Blood 2001;97:818-821.
29. Parisi T, Beck AR, Rougier N, et al. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 2003;22:4794-4803.
30. Garcia P, Frampton J, Ballester A, et al. Ectopic expression of cyclin E allows non-endomitotic megakaryoblastic K562 cells to establish re-replication cycles. Oncogene 2000;19:1820-1833.
31. Hubalek MM, Widschwendter A, Erdel M, et al. Cyclin E dysregulation and chromosomal instability in endometrial cancer. Oncogene 2004;23:4187-4192.
32. Meikrantz W, Gisselbrecht S, Tam SW, et al. Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 1994;91:3754-3758.
33. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin's lymphoma. Blood 2002;99:4283-4297.
34. Montesinos-Rongen M, Roers A, Kuppers R, et al. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 1999;94:1755-1760.